TickerFactsScreenerDevelopers

ImmunityBio, Inc. (IBRX) — Total Assets

Annual figures by fiscal year, from SEC filings.

2015: $366.85M2016: $317.50M2017: $250.44M2018: $181.95M2019: $143.12M2020: $221.38M2021: $468.91M2022: $362.36M2023: $504.45M2024: $382.93M2025: $501.90M$501.90M
2015Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$501.90M+31.1%
2024$382.93M-24.1%
2023$504.45M+39.2%
2022$362.36M-22.7%
2021$468.91M+111.8%
2020$221.38M+54.7%
2019$143.12M-21.3%
2018$181.95M-27.3%
2017$250.44M-21.1%
2016$317.50M-13.5%
2015$366.85M—